100 related articles for article (PubMed ID: 30625379)
1. Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches.
Krings A; Boateng G; Dunyo P; Amuah JE; Adams RA; Adunyame L; Nkansah DO; Wormenor CM; Hansen BT; Gedzah I; Asmah RH; Wiredu EK; Kaufmann AM
Papillomavirus Res; 2019 Jun; 7():45-51. PubMed ID: 30625379
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
[TBL] [Abstract][Full Text] [Related]
4. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
6. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
7. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM
J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
9. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
10. Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay.
Pesic A; Krings A; Schreckenberger C; Hempel M; Preyer R; Kaufmann AM
Intervirology; 2019; 62(3-4):124-133. PubMed ID: 31487743
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine.
Igidbashian S; Boveri S; Bottari F; Vidal Urbinati A; Preti E; Casadio C; Landoni F; Sideri M; Sandri MT
J Low Genit Tract Dis; 2017 Jan; 21(1):4-8. PubMed ID: 27755229
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
13. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
14. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
15. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
17. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert
Cubie HA; Morton D; Kawonga E; Mautanga M; Mwenitete I; Teakle N; Ngwira B; Walker H; Walker G; Kafwafwa S; Kabota B; Ter Haar R; Campbell C
J Clin Virol; 2017 Feb; 87():1-4. PubMed ID: 27984765
[TBL] [Abstract][Full Text] [Related]
18. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
[TBL] [Abstract][Full Text] [Related]
20. Population-based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia.
Teka B; Gizaw M; Ruddies F; Addissie A; Chanyalew Z; Skof AS; Thies S; Mihret A; Kantelhardt EJ; Kaufmann AM; Abebe T
Int J Cancer; 2021 Feb; 148(3):723-730. PubMed ID: 32875552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]